GLP 1: Just a wonder drug or a lifesaver for millions?
April 21, 2025 | Infographics
India stands tall as the world’s pharmacy — now poised to lead the GLP-1 revolution. 💉 GLP-1 receptor agonists, which mimic the hormone Glucagon-Like Peptide-1, are transforming treatment for diabetes and obesity. 🩸🧍♂️ With patents set to expire soon, India could unlock access to affordable generics, driving a healthcare breakthrough. The GLP-1 market is projected to reach $578.9M by 2030, growing at a 27.5% CAGR — a massive opportunity for India’s health and pharma sectors. 📈🚀